References
- Heng M C, Khoo M, Cooperman A, et al. Haemorrhagic cellulitis: a syndrome associated with tumor necrosis factor-alpha. Br J Dermatol 1994; 130: 65–74
- Wang K, Shih C. Necrotizing fasciitis of the extremities. J Trauma 1992; 22: 179–81
- Brantigan C O, Senkowsky J. Group A beta-hemolytic streptococcal necrotizing fasciitis. J Geriatr Dermatol 1995; 3: 68–74
- Abolinik I, Sexton D. Necrotizing fasciitis and myositis caused by group A streptococci; epidemiology, diagnosis and treatment of 'flesh-eating bacteria'. North Carolina Med J 1994; 55: 464–6
- Neuner P, Klosner G, Schauer E, et al. Pentoxifylline in vivo down regulates the release of IL-1b, IL-6, IL-8 and tumor necrosis factor-alpha by human peripheral monocytes. Immunology 1994; 83: 262–7
- Chen Y, Vraux V, Giroud J, et al. Anti-tumor necrosis factor properties of non-peptide drugs in acute phase responses. Eur J Pharmacol 1994; 271(2–3)319–27
- Smith M R, Munger W E, Kung HF, et al. Direct evidence for an intracellular role of tumor necrosis factor-alpha. J Immunol 1990; 144: 162–9
- Neta M, Blok W, Kullberg B, et al. Pharmacologic inhibitors of tumor necrosis factor production exert differential effects in lethal endotoxemia and in infection with live micro-organisms in mice. J Infect Dis 1995; 171: 393–9
- Zabel P, Wolter D, Schonharting M, et al. Oxpentoxifylline in endotoxemia. Lancet 1989; 2: 1974–6